Literature DB >> 21148405

Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.

Hee Jae Kim1, Hye Sook Ahn, Bok Hee Choi, Sang June Hahn.   

Abstract

The effects of genistein, a protein tyrosine kinase (PTK) inhibitor, on voltage-dependent K(+) (Kv) 4.3 channel were examined using the whole cell patch-clamp techniques. Genistein inhibited Kv4.3 in a reversible, concentration-dependent manner with an IC(50) of 124.78 μM. Other PTK inhibitors (tyrphostin 23, tyrphostin 25, lavendustin A) had no effect on genistein-induced inhibition of Kv4.3. Orthovanadate, an inhibitor of protein phosphatases, did not reverse the inhibition of Kv4.3 by genistein. We also tested the effects of two inactive structural analogs: genistin and daidzein. Whereas Kv4.3 was unaffected by genistin, daidzein inhibited Kv4.3, albeit with a lower potency. Genistein did not affect the activation and inactivation kinetics of Kv4.3. Genistein-induced inhibition of Kv4.3 was voltage dependent with a steep increase over the channel opening voltage range. In the full-activation voltage range positive to +20 mV, no voltage-dependent inhibition was found. Genistein had no significant effect on steady-state activation, but shifted the voltage dependence of the steady-state inactivation of Kv4.3 in the hyperpolarizing direction in a concentration-dependent manner. The K(i) for the interaction between genistein and the inactivated state of Kv4.3, which was estimated from the concentration-dependent shift in the steady-state inactivation curve, was 1.17 μM. Under control conditions, closed-state inactivation was fitted to a single exponential function, and genistein accelerated closed-state inactivation. Genistein induced a weak use-dependent inhibition. These results suggest that genistein directly inhibits Kv4.3 by interacting with the closed-inactivated state of Kv4.3 channels. This effect is not mediated via inhibition of the PTK activity, because other types of PTK inhibitors could not prevent the inhibitory action of genistein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148405      PMCID: PMC3063965          DOI: 10.1152/ajpcell.00031.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  44 in total

1.  Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells.

Authors:  S Wijetunge; C Aalkjaer; M Schachter; A D Hughes
Journal:  Biochem Biophys Res Commun       Date:  1992-12-30       Impact factor: 3.575

Review 2.  Channel regulation. Ion channel control by tyrosine phosphorylation.

Authors:  S A Siegelbaum
Journal:  Curr Biol       Date:  1994-03-01       Impact factor: 10.834

Review 3.  Modulation of ion channels by protein phosphorylation and dephosphorylation.

Authors:  I B Levitan
Journal:  Annu Rev Physiol       Date:  1994       Impact factor: 19.318

Review 4.  Regulation of potassium channels by protein kinases.

Authors:  E A Jonas; L K Kaczmarek
Journal:  Curr Opin Neurobiol       Date:  1996-06       Impact factor: 6.627

5.  Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638.

Authors:  S V Smirnov; P I Aaronson
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

6.  A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men.

Authors:  M H Gooderham; H Adlercreutz; S T Ojala; K Wähälä; B J Holub
Journal:  J Nutr       Date:  1996-08       Impact factor: 4.798

7.  Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue.

Authors:  C Y Hsu; P E Persons; A P Spada; R A Bednar; A Levitzki; A Zilberstein
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

8.  Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor.

Authors:  X Y Huang; A D Morielli; E G Peralta
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

9.  The tyrosine kinase inhibitor, genistein, prevents alpha-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway.

Authors:  J Thorburn; A Thorburn
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

10.  Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein.

Authors:  H Yokoshiki; K Sumii; N Sperelakis
Journal:  J Mol Cell Cardiol       Date:  1996-04       Impact factor: 5.000

View more
  5 in total

Review 1.  Side-effects of protein kinase inhibitors on ion channels.

Authors:  Youn Kyoung Son; Hongzoo Park; Amy L Firth; Won Sun Park
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

2.  Auxiliary KChIP4a suppresses A-type K+ current through endoplasmic reticulum (ER) retention and promoting closed-state inactivation of Kv4 channels.

Authors:  Yi-Quan Tang; Ping Liang; Jingheng Zhou; Yanxin Lu; Lei Lei; Xiling Bian; KeWei Wang
Journal:  J Biol Chem       Date:  2013-04-10       Impact factor: 5.157

3.  Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K+ current of human atria by inhibiting EGF receptor tyrosine kinase.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Wei Wu; Hai-Ying Sun; Yan Wang; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2017-02-09       Impact factor: 8.739

4.  Macrophages from elders are more permissive to intracellular multiplication of Mycobacterium tuberculosis.

Authors:  José M Guerra-Laso; Sandra González-García; Carolina González-Cortés; Cristina Diez-Tascón; Ramiro López-Medrano; Octavio M Rivero-Lezcano
Journal:  Age (Dordr)       Date:  2012-07-12

5.  Effects of equol on multiple K+ channels stably expressed in HEK 293 cells.

Authors:  Xiu-Ling Deng; Yan Wang; Guo-Sheng Xiao
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.